New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice

A new biological model of moderate inhibition of tumor growth and metastases with prolonged leukopenia on C57BI/6 mice with the Lewis Lung Carcinoma was designed. The model was created by the injection of cyclophosphamide (dose 83.3 mg/kg) on 6th, 12th, 18th days after tumor cells transplantation on...

Full description

Bibliographic Details
Main Authors: O. Y. Rybalkina, N. N. Ermakova, T. G. Razina, E. G. Skurikhin, E. P. Zueva
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2016-09-01
Series:Acta Biomedica Scientifica
Subjects:
Online Access:https://www.actabiomedica.ru/jour/article/view/292
_version_ 1797237401292111872
author O. Y. Rybalkina
N. N. Ermakova
T. G. Razina
E. G. Skurikhin
E. P. Zueva
author_facet O. Y. Rybalkina
N. N. Ermakova
T. G. Razina
E. G. Skurikhin
E. P. Zueva
author_sort O. Y. Rybalkina
collection DOAJ
description A new biological model of moderate inhibition of tumor growth and metastases with prolonged leukopenia on C57BI/6 mice with the Lewis Lung Carcinoma was designed. The model was created by the injection of cyclophosphamide (dose 83.3 mg/kg) on 6th, 12th, 18th days after tumor cells transplantation on animals. Experiment showed that 3-fold cyclophosphamide use leads to growth of primary tumor and metastases inhibition. Tumor growth inhibition was 34 % on 21st day after cyclophosphamide inject. The number of metastases decreased by 4.7 times (p < 0,01). Metastatic area reduced. Metastasis frequency made 100 %. In addition, the course of cyclophosphamide application caused inhibition of granulocytic and lymphoid hematopoiesis. The reducing the number of segmented neutrophils and lymphocytes was showed on the 3rd day after 1, 2 and 3 injections of cyclophosphamide. The model can be used to study the efficacy of drugs in tumor therapy and in correction of such toxic manifestation of chemotherapy as leukopenia.
first_indexed 2024-03-08T12:18:51Z
format Article
id doaj.art-47512e2174f547a4941b5e2961d55fea
institution Directory Open Access Journal
issn 2541-9420
2587-9596
language Russian
last_indexed 2024-04-24T17:19:10Z
publishDate 2016-09-01
publisher Scientific Сentre for Family Health and Human Reproduction Problems
record_format Article
series Acta Biomedica Scientifica
spelling doaj.art-47512e2174f547a4941b5e2961d55fea2024-03-28T07:49:16ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962016-09-011512112510.12737/23406292New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in miceO. Y. Rybalkina0N. N. Ermakova1T. G. Razina2E. G. Skurikhin3E. P. Zueva4Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State UniversityGoldberg Research Institute of Pharmacology and Regenerative MedicineGoldberg Research Institute of Pharmacology and Regenerative MedicineGoldberg Research Institute of Pharmacology and Regenerative MedicineGoldberg Research Institute of Pharmacology and Regenerative MedicineA new biological model of moderate inhibition of tumor growth and metastases with prolonged leukopenia on C57BI/6 mice with the Lewis Lung Carcinoma was designed. The model was created by the injection of cyclophosphamide (dose 83.3 mg/kg) on 6th, 12th, 18th days after tumor cells transplantation on animals. Experiment showed that 3-fold cyclophosphamide use leads to growth of primary tumor and metastases inhibition. Tumor growth inhibition was 34 % on 21st day after cyclophosphamide inject. The number of metastases decreased by 4.7 times (p < 0,01). Metastatic area reduced. Metastasis frequency made 100 %. In addition, the course of cyclophosphamide application caused inhibition of granulocytic and lymphoid hematopoiesis. The reducing the number of segmented neutrophils and lymphocytes was showed on the 3rd day after 1, 2 and 3 injections of cyclophosphamide. The model can be used to study the efficacy of drugs in tumor therapy and in correction of such toxic manifestation of chemotherapy as leukopenia.https://www.actabiomedica.ru/jour/article/view/292experimental modelcyclophosphamidelewis lung carcinomaleukopenia
spellingShingle O. Y. Rybalkina
N. N. Ermakova
T. G. Razina
E. G. Skurikhin
E. P. Zueva
New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
Acta Biomedica Scientifica
experimental model
cyclophosphamide
lewis lung carcinoma
leukopenia
title New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
title_full New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
title_fullStr New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
title_full_unstemmed New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
title_short New biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
title_sort new biological model of moderate inhibition of tumor and metastases growth with prolonged leukopenia in mice
topic experimental model
cyclophosphamide
lewis lung carcinoma
leukopenia
url https://www.actabiomedica.ru/jour/article/view/292
work_keys_str_mv AT oyrybalkina newbiologicalmodelofmoderateinhibitionoftumorandmetastasesgrowthwithprolongedleukopeniainmice
AT nnermakova newbiologicalmodelofmoderateinhibitionoftumorandmetastasesgrowthwithprolongedleukopeniainmice
AT tgrazina newbiologicalmodelofmoderateinhibitionoftumorandmetastasesgrowthwithprolongedleukopeniainmice
AT egskurikhin newbiologicalmodelofmoderateinhibitionoftumorandmetastasesgrowthwithprolongedleukopeniainmice
AT epzueva newbiologicalmodelofmoderateinhibitionoftumorandmetastasesgrowthwithprolongedleukopeniainmice